PER 1.23% 8.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-71

  1. 300 Posts.
    lightbulb Created with Sketch. 833
    Hi Sam... thanks also for all your informative and straight assessments.

    How it is possible in a blinded trial was also asked of the company... whereas the efficacy data is blinded, safety is not. As with all trials I guess, safety is constantly monitored. I dont have an answer for the placebo part but maybe they will be using natural history and not placebo...

    I will get my contact to follow up and see if we can shed some light on the issue.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.